Patent
Method for promoting neural growth comprising administering a soluble neural cell adhesion molecule
Reads0
Chats0
TLDR
In this paper, a method for promoting neural growth in vivo in the mammalian central nervous system by administering a neural cell adhesion molecule which can overcome inhibitory molecular cues found on glial cells and myelin to promote neural growth.Abstract:
The invention features a method for promoting neural growth in vivo in the mammalian central nervous system by administering a neural cell adhesion molecule which can overcome inhibitory molecular cues found on glial cells and myelin to promote neural growth. Also featured active fragments, cognates, congeners, mimics, analogs, secreting cells and soluble molecules thereof, as well as antibodies thereto, and DNA molecules, vectors and transformed cells capable of expressing them. The invention also includes transgenic mouse lines expressing a neural adhesion molecule in differentiated astrocytes, and cells and tissues derived therefrom. The expression of the neural adhesion molecule enhances neurite outgrowth on central nervous system tissue derived from these transgenic mice. The invention also features methods for enhancing neuronal outgrowth of CNS neurons, for enhancing memory and for increasing synaptic efficacy. Also featured are methods of testing drugs which modulate the effects of the neural adhesion molecule, and assay systems suitable for such methods.read more
Citations
More filters
Patent
Biologic modulations with nanoparticles
TL;DR: In this paper, the use of small particles in biological systems, including the delivery of biologically active agents to cells or tissues using nanoparticles of less than about 200 nm in approximate diameter, was discussed.
Patent
Nanoparticle delivery systems and methods of use thereof
TL;DR: In this article, a collection of particles comprising an agent, a surfactant molecule having an HLB value of less than about 6.0 units, and a polymer soluble in aqueous solution was used to deliver biologically active agents.
Patent
Peptides That Stimulate Cell Survival and Axon Regeneration
TL;DR: In this article, the tetrameric peptide structural unit: Xaa-Xaa -Xaa-xaa-xi-aa-si -si-siXaa (SEQ.ID.No.
Patent
Compositions and methods for the treatment of cns injuries
TL;DR: In this article, a method of improving functional recovery following a central nervous system contusion injury was proposed, which includes administering a therapeutically effective amount of glycosaminoglycan degrading enzyme.
Patent
Proteoglycan degrading mutants for treatment of cns
TL;DR: The present disclosure relates to the preparation and deletion mutants of chondroitinase proteins and their use in methods for promoting the diffusion of therapeutic composition into tissues and its use for neurological functional recovery after central nervous system ('CNS') injury or disease as mentioned in this paper.
References
More filters
Patent
Laminin a chain deduced amino acid sequence, expression vectors and active synthetic peptides
TL;DR: In this paper, a laminin-like activity was found in peptides and derivatives of these peptides, which may be used to treat diseases such as cancer, such as prostate cancer.
Book
The adhesion molecule factsbook
Rod Pigott,Christine Power +1 more
TL;DR: The chiral stationary phase trial showed promising results inoters with high chiral recognition ability, particularly in relation to Leukocyte Adhesion Receptor Gp11b/111a.
Patent
Neural cell adhesion protein nerve prosthesis
TL;DR: The neural cell adhesion molecule is used in nerve prostheses for the repair of peripheral nerve damage in mammals, both animal and man as discussed by the authors, in a process wherein a crushed or severed nerve ending is entubulated by use of a prosthetic device.
Patent
Antagonism of central nervous system drugs by the administration of 4-aminopyridine alone or in combination with other drugs
TL;DR: The use of 4-aminopyridine and derivatives thereof to antagonize drugs which act at or upon central nervous system receptors, especially dopamine receptors, such as butyrophenones and congeners or derivatives thereof is disclosed.
Patent
Antibody to the neural cell adhesion molecule and methods of use
TL;DR: In this paper, an anti-N-CAM monoclonal antibody which enhances neurite outgrowth both in vitro and in vivo is presented, which has positive regulatory effects on nerve cells of both the central and peripheral nervous systems.